Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* At least 10 years of age \& either sex, any race~* Willing and able to follow all instructions and attend all study visits~* Positive history of ocular allergies~Exclusion Criteria:~* Have planned surgery during trial period~* Female currently pregnant, planning a pregnancy, or lactating

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Bepreve (Type: EXPERIMENTAL): Bepotastine Besilate Ophthalmic Solution 1.5%
- Placebo (Type: PLACEBO_COMPARATOR): sterile ophthalmic solution
- Bepotastine Besilate (Type: EXPERIMENTAL): sterile ophthalmic solution 1.0%

Based on this trial design, predict the completion outcome and termination type (if applicable).